A circulating microRNA panel enhances the diagnosis of cholangiocarcinoma
PLOS One · 25.09.2025 · 20 (9) · e0333279
DOI: 10.1371/journal.pone.0333279 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 25.09.2025. Verfasst von Aye Myat Mon und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Technology Program, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, Biomarkers, Tumor, MicroRNAs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Fund of Khon Kaen University, under the National Science, Research and Innovation Fund, KKU Scholarship for ASEAN and GMS countries’ personnel in the 2019 academic year at Khon Kaen University, National Research Council of Thailand.
Abstract (Originalsprache)
Background and aim Cholangiocarcinoma (CCA), a malignancy with a high incidence in regions endemic for the liver fluke Opisthorchis viverrini , is frequently characterized by alterations in the p53 tumor-suppressor gene, a process often modulated by microRNAs. Our study aimed to identify circulating miRNAs as potential diagnostic biomarkers for CCA.
Methods
We sequenced small RNAs to identify differentially expressed microRNAs (miRNAs) in two CCA cell lines (one p53-mutant, one p53-wildtype) relative to an immortalized cholangiocyte cell line. Candidate miRNAs exhibiting significant upregulation with a log2 fold change > 4.5 were selected for validation via RT-qPCR in serum samples from patients with CCA. The diagnostic utility of these serum miRNAs was subsequently evaluated using receiver operating characteristic (ROC) analysis to assess their ability to distinguish CCA from normal controls and hepatocellular carcinoma (HCC). This performance was assessed for the miRNAs as standalone markers and in combination with conventional tumor markers.
Results
Analysis of miRNA expression profiles identified seven upregulated candidates for validation. Among these, serum levels of miR-99a-5p, miR-516a-5p, and miR-526b-5p were significantly elevated in patients with CCA compared to both normal controls (all area under the curve, AUC > 0.79, p < 0.0001) and patients with HCC (all AUC > 0.80, p < 0.0001). A diagnostic panel combining these three miRNAs demonstrated high accuracy in distinguishing CCA from normal controls (AUC = 0.899) and from HCC (AUC = 0.937). The panel’s performance was further enhanced by incorporating conventional tumor markers, achieving an AUC of 0.928 when combined with CA19−9, and rising to 0.959 with the inclusion of both CA19−9 and CEA.
Conclusions
These findings indicate that a panel comprising miR-99a-5p, miR-516a-5p, and miR-526b-5p, alone or with established tumor markers, offers high accuracy as a minimally invasive diagnostic tool for CCA, and can effectively distinguish it from HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Technology Program, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.
- Cholangiocarcinoma Research Institute, Faculty of Medicine, Khon Kaen University, Thailand.
- Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
- Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
- Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.
- Department of Surgery, Faculty of Medicine, Khon Kaen UniversityKhon Kaen, Thailand.
ORCID-Profile: Porntip Pinlaor
Förderung
- Fundamental Fund of Khon Kaen University, under the National Science, Research and Innovation Fund
- KKU Scholarship for ASEAN and GMS countries’ personnel in the 2019 academic year at Khon Kaen University
- National Research Council of Thailand
- Thailand Science Research and Innovation Fundamental Fund
Zitieren
APA
Mon, A. M., Intuyod, K., Klungsaeng, S., Jusakul, A., Sangka, A., Luvira, V., Pairojkul, C., Plengsuriyakarn, T., Na-Bangchang, K., Pinlaor, S., & Pinlaor, P. (2025). A circulating microRNA panel enhances the diagnosis of cholangiocarcinoma. PLOS One, 20(9), e0333279. https://doi.org/10.1371/journal.pone.0333279
Vancouver
Mon AM, Intuyod K, Klungsaeng S, Jusakul A, Sangka A, Luvira V, et al. A circulating microRNA panel enhances the diagnosis of cholangiocarcinoma. PLOS One. 2025;20(9):e0333279. doi:10.1371/journal.pone.0333279
BibTeX
@article{Mon2025,
author = {Mon, Aye Myat and Intuyod, Kitti and Klungsaeng, Sirinapha and Jusakul, Apinya and Sangka, Arunnee and Luvira, Vor and Pairojkul, Chawalit and Plengsuriyakarn, Tullayakorn and Na-Bangchang, Kesara and Pinlaor, Somchai and Pinlaor, Porntip},
title = {A circulating microRNA panel enhances the diagnosis of cholangiocarcinoma},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {9},
pages = {e0333279},
doi = {10.1371/journal.pone.0333279}
}
EUVIMED